Condition
Breast Cancer (Early Breast Cancer) clinical trials and research
As of November 12, 2026, Find a Trial lists 7 Breast Cancer (Early Breast Cancer) clinical trials that are recruiting, at sites in 36 countries (most in France (3), Spain (2), Argentina (2)). By phase: Phase 2 (1), Phase 3 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 7Clinical trials
- 36Countries
Newest Breast Cancer (Early Breast Cancer) clinical trials
| Study | Phase | Where | Status | Registered |
|---|---|---|---|---|
| Skipping hormone therapy for some low-risk early breast cancer patients | Phase 2 | Angers and 40 other locations | Recruiting | Jun 22, 2026 |
| Cardiac Side Effects of Systemic Therapy in Early-Stage Breast Cancer | — | Ankara, Ankara | Recruiting | May 14, 2026 |
| Liquid-nitrogen cryoablation for small luminal breast tumors | — | Lugo, Lugo | Recruiting | Mar 3, 2026 |
| Real-world use of EndoPredict to guide treatment in early HR+/HER2- breast cancer | — | Paris | Recruiting | Feb 2, 2026 |
| Oncoliq blood test for early detection of breast cancer | — | Buenos Aires, Buenos Aires | Recruiting | Jan 12, 2026 |
| Evaluating camizestrant for early breast cancer after standard therapy | Phase 3 | Birmingham, Alabama and 708 other locations | Recruiting | Mar 20, 2023 |
| Observational study on breast cancer patients with early and advanced stages | — | Böblingen, Baden-Wurttemberg and 60 other locations | Recruiting | Jan 14, 2015 |
All recruiting trials (7)
-
Skipping hormone therapy for some low-risk early breast cancer patients
This trial tests whether certain older, postmenopausal women with very small, low-risk ER-positive HER2-negative breast cancers can skip hormone therapy after surgery without raising the chance of cancer coming back.
-
Cardiac Side Effects of Systemic Therapy in Early-Stage Breast Cancer
This study tests whether heart changes seen on ultrasound and blood biomarkers can detect early heart problems in women receiving standard chemotherapy and anti-HER2 therapy for early breast cancer.
-
Liquid-nitrogen cryoablation for small luminal breast tumors
This trial will try liquid-nitrogen cryoablation to destroy small (≤2 cm) luminal breast cancers in postmenopausal women before surgical removal.
-
Real-world use of EndoPredict to guide treatment in early HR+/HER2- breast cancer
This tests whether the EndoPredict genomic test can predict 10-year relapse risk and help decide if people with early HR+/HER2- breast cancer need chemotherapy in addition to hormone therapy.
-
Oncoliq blood test for early detection of breast cancer
This project will test whether a blood-based miRNA panel (the Oncoliq Test) can detect early breast cancer in adults 40–70 by comparing newly diagnosed, untreated patients with cancer-free controls.
-
Evaluating camizestrant for early breast cancer after standard therapy
This study is testing if a new drug called camizestrant can help women with early breast cancer who have finished standard hormone therapy to live longer and stay cancer-free.
-
Observational study on breast cancer patients with early and advanced stages
This study is trying to see if testing the biology of tumors in breast cancer patients can help doctors make better treatment choices for those with early and advanced stages of the disease.
Related topics
Quick answers
How many Breast Cancer (Early Breast Cancer) clinical trials are recruiting right now?
7, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 36 countries. The most sites are in France (3 trials), Spain (2 trials), Argentina (2 trials), Turkey (Türkiye) (2 trials), Germany (2 trials). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 2: 1, Phase 3: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.